drugset / Trial / NCT04607850

Prime-boost Vaccine Study in Women With Low-grade Cervical HPV Lesions

NCT04607850 ↗

Phase 1/2 Completed 108 enrolled Barinthus Biotherapeutics
RandomizedSequentialQuadruple-blindTreatment

Summary

A Phase 1b/2 multi-centre study evaluating the safety, efficacy and immunogenicity of prime-boost vaccines ChAdOx1-HPV and MVA-HPV in women with HPV related low grade cervical lesions.

Timeline

Start
2021-03-16
Primary completion
2024-01-16
Completion
2024-01-16

Drugs

EvaluationDrugModalityDoseRoute
Subject ChAdOx1-HPV Vaccine 2e+08 unknown —
Subject ChAdOx1-HPV Vaccine 2e+09 unknown —
Subject ChAdOx1-HPV Vaccine 2e+10 unknown —
Subject MVA-HPV Vaccine 1e+07 unknown —
Subject MVA-HPV Vaccine 1e+08 unknown —